SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-035368
Filing Date
2023-03-22
Accepted
2023-03-22 08:07:32
Documents
14
Period of Report
2023-03-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2310079d1_8k.htm   iXBRL 8-K 27362
2 EXHIBIT 99.1 tm2310079d1_ex99-1.htm EX-99.1 70954
6 GRAPHIC tm2310079d1_ex99-1img001.jpg GRAPHIC 15608
  Complete submission text file 0001104659-23-035368.txt   304823

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxs-20230322.xsd EX-101.SCH 3037
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20230322_lab.xml EX-101.LAB 34477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20230322_pre.xml EX-101.PRE 22598
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2310079d1_8k_htm.xml XML 3615
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 23751458
SIC: 2834 Pharmaceutical Preparations